|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013227,
umls-concept:C0019693,
umls-concept:C0027947,
umls-concept:C0079459,
umls-concept:C0183683,
umls-concept:C0210630,
umls-concept:C0344211,
umls-concept:C1171411,
umls-concept:C1257890,
umls-concept:C1292734,
umls-concept:C1317973,
umls-concept:C1521721,
umls-concept:C1522326,
umls-concept:C2603343
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
1997-3-12
|
|
pubmed:abstractText |
Patients with HIV infection frequently experience disease or treatment-related myelosuppression leading to neutropenia. Neutropenia often leads to dose-reduction or discontinuation of important myelosuppressive therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
pubmed-author:AmmassariAA,
pubmed-author:BorleffsJJ,
pubmed-author:CastelliFF,
pubmed-author:ClumeckNN,
pubmed-author:De BonaAA,
pubmed-author:FerréCC,
pubmed-author:GoriAA,
pubmed-author:GraySS,
pubmed-author:HermannWW,
pubmed-author:JogSS,
pubmed-author:LangJ MJM,
pubmed-author:LongoVV,
pubmed-author:RozenbaumWW,
pubmed-author:WardNN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1627-33
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8970682-Adolescent,
pubmed-meshheading:8970682-Adult,
pubmed-meshheading:8970682-Aged,
pubmed-meshheading:8970682-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:8970682-HIV Infections,
pubmed-meshheading:8970682-HIV-1,
pubmed-meshheading:8970682-Humans,
pubmed-meshheading:8970682-Injections, Subcutaneous,
pubmed-meshheading:8970682-Middle Aged,
pubmed-meshheading:8970682-Neutropenia,
pubmed-meshheading:8970682-Recombinant Proteins
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. G-CSF 92105 Study Group.
|
|
pubmed:affiliation |
Department of Infectious Diseases, Saint-Pierre University Hospital, Brussels, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
